Fouad Attieh

11PUBLICATIONS
11CO-AUTHORS
Haematological tumoursCancer cell biologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Dec 11, 2025
Is escalated BEACOPP dead? Rethinking standards in hodgkin lymphoma treatment.

Colette Hanna, Fouad Attieh, Hampig Raphaël Kourie

|Jun 18, 2025
Enter sandman: how to tackle dormant breast cancer cells.

Fouad Attieh, Reina Al Khatib, Marc Boutros

|Dec 23, 2024
Tumor mutational burden: why is it still a controversial agnostic immunotherapy biomarker?

Antoine Mouawad, Marc Boutros, Antoine Chartouni

|Sep 05, 2024
Turning the tide: pembrolizumab's triumph in adjuvant RCC therapy.

Fouad Attieh, Marc Boutros, Hampig Raphaël Kourie

|Jun 17, 2024
A critical review of RAF inhibitors in BRAF-mutated glioma treatment.

John-Victor El Khoury, Sophie Wehbe, Fouad Attieh

|Jun 11, 2024
How to find a needle in a haystack: a systematic review on targeting KRAS wild-type pancreatic cancer.

Antoine Mouawad, Sofia Habib, Marc Boutros

Pageof 2